BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15279587)

  • 1. Immune restoration disease: a consequence of dysregulated immune responses after HAART.
    Stone SF; Price P; French MA
    Curr HIV Res; 2004 Jul; 2(3):235-42. PubMed ID: 15279587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.
    Price P; Mathiot N; Krueger R; Stone S; Keane NM; French MA
    J Clin Virol; 2001 Oct; 22(3):279-87. PubMed ID: 11564593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Stone SF; French MA
    Clin Exp Immunol; 2001 Oct; 126(1):111-6. PubMed ID: 11678906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune restoration disease after antiretroviral therapy.
    French MA; Price P; Stone SF
    AIDS; 2004 Aug; 18(12):1615-27. PubMed ID: 15280772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.
    Jevtović DJ; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2005 Mar; 6(2):140-3. PubMed ID: 15807721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.
    Lawn SD; Bekker LG; Miller RF
    Lancet Infect Dis; 2005 Jun; 5(6):361-73. PubMed ID: 15919622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.
    French M; Price P
    J HIV Ther; 2002 May; 7(2):46-51. PubMed ID: 12553688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment.
    Stone SF; Price P; Tay-Kearney ML; French MA
    J Infect Dis; 2002 Jun; 185(12):1813-7. PubMed ID: 12085331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC haplotypes affect the expression of opportunistic infections in HIV patients.
    Price P; Keane NM; Stone SF; Cheong KY; French MA
    Hum Immunol; 2001 Feb; 62(2):157-64. PubMed ID: 11182226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.
    de Boer MG; Kroon FP; Kauffmann RH; Vriesendorp R; Zwinderman K; van Dissel JT
    Neth J Med; 2003 Dec; 61(12):408-12. PubMed ID: 15025416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.
    Price P; Morahan G; Huang D; Stone E; Cheong KY; Castley A; Rodgers M; McIntyre MQ; Abraham LJ; French MA
    AIDS; 2002 Oct; 16(15):2043-7. PubMed ID: 12370503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease.
    Seddiki N; Sasson SC; Santner-Nanan B; Munier M; van Bockel D; Ip S; Marriott D; Pett S; Nanan R; Cooper DA; Zaunders JJ; Kelleher AD
    Eur J Immunol; 2009 Feb; 39(2):391-403. PubMed ID: 19180462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients.
    Stone SF; Lee S; Keane NM; Price P; French MA
    J Infect Dis; 2002 Nov; 186(10):1498-502. PubMed ID: 12404169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.
    Stone SF; Price P; Keane NM; Murray RJ; French MA
    HIV Med; 2002 Jan; 3(1):21-7. PubMed ID: 12059947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.
    French MA; Lenzo N; John M; Mallal SA; McKinnon EJ; James IR; Price P; Flexman JP; Tay-Kearney ML
    HIV Med; 2000 Mar; 1(2):107-15. PubMed ID: 11737333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.
    Tangsinmankong N; Kamchaisatian W; Lujan-Zilbermann J; Brown CL; Sleasman JW; Emmanuel PJ
    J Allergy Clin Immunol; 2004 Apr; 113(4):742-6. PubMed ID: 15100682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.